Discontinued — last reported Q2 '21
Xylem Loss on Sale of Subsidiary increased by 110.8% to $4.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 140.0%, from -$10.00M to $4.00M. Over 3 years (FY 2021 to FY 2024), Loss on Sale of Subsidiary shows a downward trend with a 184.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A loss suggests the asset was sold for less than its book value, potentially indicating poor past investment performance.
This metric captures the non-cash accounting loss recognized when a subsidiary or business unit is divested. It represen...
Rare for stable firms; common during periods of portfolio optimization or divestiture programs.
unh_loss_on_sale_of_subsidiary| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.00M | $0.00 | $0.00 | $1.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$1.00M | -$5.00M | $1.00M | -$2.00M | -$40.00M | -$10.00M | $0.00 | -$37.00M | $4.00M |
| QoQ Change | — | -100.0% | — | — | -100.0% | — | — | — | — | — | — | -400.0% | +120.0% | -300.0% | <-999% | +75.0% | +100.0% | — | +110.8% |
| YoY Change | — | — | — | — | -100.0% | — | — | -100.0% | — | — | — | — | — | — | <-999% | -100.0% | -100.0% | <-999% | +140.0% |